Loading company…
View Gene develops gene therapies for ophthalmic, skin, blood, and central nervous system diseases.
Founded in 2021 in Suzhou, China, View Gene is a gene therapy company led by founder Jiye Wei, who has experience in gene therapy industrialization and switch-modulated gene therapy. The team has experience in AAV vector design and industrialization. Its inducible and tissue-specific platforms support a pipeline addressing ophthalmic, dermatological, hematological, and central nervous system diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in